Casandra
Casandra Test Code LC56284Version 1 (DRAFT)
Performing Lab
Ovarian Cancer Monitor
Clinical Use
Order TestUse
Use of HE4 in combination with CA 125 provides a more accurate predictor of malignancy than either marker alone.
Special Instructions
Not provided.
Limitations
The results from the Ovarian Cancer Monitor should not be considered absolute evidence of the presence or absence of malignant disease. Values obtained using different assay methods or kits are not interchangeable, and precautions should be taken when interpreting results.
Test Details
Methodology
Immunoassay (ELISA)
Biomarkers
CA 125
ProteinConcentration
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
HE4
ProteinConcentration
Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
LOINC Codes
Result Codes
- 10334-1 - Cancer Ag125 SerPl-aCnc
- 55180-4 - HE4 SerPl-sCnc
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.8 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
If red-top tube is used, transfer separated serum to a plastic transport tube.
Storage Instructions
Refrigerate
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Similar Tests
Other tests from different labs that may be relevant
HE4, Ovarian Cancer Monitoring
Quest Diagnostics
Human Epididymis Protein 4, Serum
Mayo Clinic Lab
Human Epididymis Protein 4 (HE4)
ARUP Laboratories
Cancer Antigen 125 (CA 125), Serum
Mayo Clinic Lab
CA 125
Quest Diagnostics
ROMA® (Risk of Ovarian Malignancy Algorithm)
Quest Diagnostics
Risk of Ovarian Malignancy Algorithm
ARUP Laboratories
Risk Score, if Postmenopausal, Serum
Mayo Clinic Lab
CA 125 with HAMA Treatment
Quest Diagnostics
Malignancy Risk Assessment, Pelvic Mass, OVA1 Plus
ARUP Laboratories